Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Uusitupa, M.
Right arrow Articles by Tuomilehto, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Uusitupa, M.
Right arrow Articles by Tuomilehto, J.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 52:2532-2538, 2003
© 2003 by the American Diabetes Association, Inc.

Long-Term Improvement in Insulin Sensitivity by Changing Lifestyles of People with Impaired Glucose Tolerance

4-Year Results From the Finnish Diabetes Prevention Study

Matti Uusitupa1, Virpi Lindi1, Anne Louheranta1, Titta Salopuro1, Jaana Lindström2, and Jaakko Tuomilehto2 for the Finnish Diabetes Prevention Study Group

1 Department of Clinical Nutrition, University of Kuopio, Kuopio, Finland
2 Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion National Public Health Institute, Helsinki, Finland

Lifestyle interventions reduce the incidence of type 2 diabetes among individuals with impaired glucose tolerance (IGT). However, it is unknown whether this is due to improved insulin sensitivity or insulin secretion. We investigated at baseline insulin sensitivity and insulin secretion applying frequently sampled intravenous glucose tolerance test (FSIGT) in 87 of 101 obese middle-aged subjects with IGT randomized into an intervention or a control group in the Finnish Diabetes Prevention Study. FSIGT was repeated after 4 years in 52 people. There were no significant differences in any of the baseline anthropometric or metabolic characteristics between the groups. The 4-year weight and waist circumference decreases were greater in the intervention than in the control group (P = 0.043 and P = 0.025, respectively). At 4-year examination, insulin sensitivity (Si) tended to be higher in the intervention group (the difference between the mean values 36%; P = 0.067, and P = 0.136 after adjustment for age, sex, BMI, and baseline Si value). There was strong correlation between the 4-year changes in Si and weight (r = -0.628 and r = -0.710, for intervention and control groups; P < 0.001 for both). In the entire group, Si improved by 64% in the highest tertile of weight loss but deteriorated by 24% in those who gained weight (lowest tertile). Acute insulin response declined significantly in the control group. In conclusion, Si markedly improved by weight reduction during the 4-year follow-up of individuals with IGT. Insulin secretion remained constant for years in individuals with IGT who were able to lose weight.


Address correspondence and reprint requests to Prof. Matti Uusitupa, Department of Clinical Nutrition, University of Kuopio, P.O. Box 1627, FIN-70211 Kuopio, Finland. E-mail: matti.uusitupa{at}uku.fi


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
G. Nijpels, W. Boorsma, J. M. Dekker, F. Hoeksema, P. J. Kostense, L. M. Bouter, and R. J. Heine
Absence of an Acute Insulin Response Predicts Onset of Type 2 Diabetes in a Caucasian Population with Impaired Glucose Tolerance
J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2633 - 2638.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. Gastaldelli
Abdominal fat: does it predict the development of type 2 diabetes?
Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1118 - 1119.
[Full Text] [PDF]


Home page
Diabetes CareHome page
P. Ilanne-Parikka, J. G. Eriksson, J. Lindstrom, M. Peltonen, S. Aunola, H. Hamalainen, S. Keinanen-Kiukaanniemi, M. Laakso, T. T. Valle, J. Lahtela, et al.
Effect of Lifestyle Intervention on the Occurrence of Metabolic Syndrome and its Components in the Finnish Diabetes Prevention Study
Diabetes Care, April 1, 2008; 31(4): 805 - 807.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
U. Riserus, J. Arnlov, and L. Berglund
Long-Term Predictors of Insulin Resistance: Role of lifestyle and metabolic factors in middle-aged men
Diabetes Care, November 1, 2007; 30(11): 2928 - 2933.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
T. O. Kilpelainen, T. A. Lakka, D. E. Laaksonen, O. Laukkanen, J. Lindstrom, J. G. Eriksson, T. T. Valle, H. Hamalainen, S. Aunola, P. Ilanne-Parikka, et al.
Physical activity modifies the effect of SNPs in the SLC2A2 (GLUT2) and ABCC8 (SUR1) genes on the risk of developing type 2 diabetes
Physiol Genomics, October 19, 2007; 31(2): 264 - 272.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
P. Kallio, M. Kolehmainen, D. E Laaksonen, J. Kekalainen, T. Salopuro, K. Sivenius, L. Pulkkinen, H. M Mykkanen, L. Niskanen, M. Uusitupa, et al.
Dietary carbohydrate modification induces alterations in gene expression in abdominal subcutaneous adipose tissue in persons with the metabolic syndrome: the FUNGENUT Study
Am. J. Clinical Nutrition, May 1, 2007; 85(5): 1417 - 1427.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. Herder, M. Peltonen, W. Koenig, I. Kraft, S. Muller-Scholze, S. Martin, T. Lakka, P. Ilanne-Parikka, J. G. Eriksson, H. Hamalainen, et al.
Systemic Immune Mediators and Lifestyle Changes in the Prevention of Type 2 Diabetes: Results From the Finnish Diabetes Prevention Study.
Diabetes, August 1, 2006; 55(8): 2340 - 2346.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
S. M. Haffner
Abdominal obesity, insulin resistance, and cardiovascular risk in pre-diabetes and type 2 diabetes
Eur. Heart J. Suppl., May 1, 2006; 8(suppl_B): B20 - B25.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
D. E Laaksonen, L. K Toppinen, K. S Juntunen, K. Autio, K.-H. Liukkonen, K. S Poutanen, L. Niskanen, and H. M Mykkanen
Dietary carbohydrate modification enhances insulin secretion in persons with the metabolic syndrome
Am. J. Clinical Nutrition, December 1, 2005; 82(6): 1218 - 1227.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. S. Bassuk and J. E. Manson
Epidemiological evidence for the role of physical activity in reducing risk of type 2 diabetes and cardiovascular disease
J Appl Physiol, September 1, 2005; 99(3): 1193 - 1204.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
The Diabetes Prevention Program Research Group
Role of Insulin Secretion and Sensitivity in the Evolution of Type 2 Diabetes in the Diabetes Prevention Program: Effects of Lifestyle Intervention and Metformin
Diabetes, August 1, 2005; 54(8): 2404 - 2414.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
O. Laukkanen, J. Lindstrom, J. Eriksson, T. T. Valle, H. Hamalainen, P. Ilanne-Parikka, S. Keinanen-Kiukaanniemi, J. Tuomilehto, M. Uusitupa, and M. Laakso
Polymorphisms in the SLC2A2 (GLUT2) Gene Are Associated With the Conversion From Impaired Glucose Tolerance to Type 2 Diabetes: The Finnish Diabetes Prevention Study
Diabetes, July 1, 2005; 54(7): 2256 - 2260.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M.-E. Piche, S. J. Weisnagel, L. Corneau, A. Nadeau, J. Bergeron, and S. Lemieux
Contribution of Abdominal Visceral Obesity and Insulin Resistance to the Cardiovascular Risk Profile of Postmenopausal Women
Diabetes, March 1, 2005; 54(3): 770 - 777.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. B. Carr, K. M. Utzschneider, E. J. Boyko, P. J. Asberry, R. L. Hull, K. Kodama, H. S. Callahan, C. C. Matthys, D. L. Leonetti, R. S. Schwartz, et al.
A Reduced-Fat Diet and Aerobic Exercise in Japanese Americans With Impaired Glucose Tolerance Decreases Intra-Abdominal Fat and Improves Insulin Sensitivity but not {beta}-Cell Function
Diabetes, February 1, 2005; 54(2): 340 - 347.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. E. Laaksonen, J. Lindstrom, T. A. Lakka, J. G. Eriksson, L. Niskanen, K. Wikstrom, S. Aunola, S. Keinanen-Kiukaanniemi, M. Laakso, T. T. Valle, et al.
Physical Activity in the Prevention of Type 2 Diabetes: The Finnish Diabetes Prevention Study
Diabetes, January 1, 2005; 54(1): 158 - 165.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
D. C Anderson Jr
Pharmacologic Prevention or Delay of Type 2 Diabetes Mellitus
Ann. Pharmacother., January 1, 2005; 39(1): 102 - 109.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
O. Laukkanen, J. Pihlajamaki, J. Lindstrom, J. Eriksson, T. T. Valle, H. Hamalainen, P. Ilanne-Parikka, S. Keinanen-Kiukaanniemi, J. Tuomilehto, M. Uusitupa, et al.
Polymorphisms of the SUR1 (ABCC8) and Kir6.2 (KCNJ11) Genes Predict the Conversion from Impaired Glucose Tolerance to Type 2 Diabetes. The Finnish Diabetes Prevention Study
J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6286 - 6290.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J.-L. Chiasson and R. Rabasa-Lhoret
Prevention of Type 2 Diabetes: Insulin Resistance and Beta-Cell Function
Diabetes, December 1, 2004; 53(suppl_3): S34 - S38.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. Klein, L. Fontana, V. L. Young, A. R. Coggan, C. Kilo, B. W. Patterson, and B. S. Mohammed
Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease
N. Engl. J. Med., June 17, 2004; 350(25): 2549 - 2557.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2003 by the American Diabetes Association.